Cargando…
Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases
BACKGROUND: Chronic spontaneous urticaria (CSU) has a detrimental effect on patients’ emotional and physical quality of life. Omalizumab, an anti-immunoglobulin E humanized monoclonal antibody, has been shown to be very effective in the treatment of refractory chronic urticaria patients but may not...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966419/ https://www.ncbi.nlm.nih.gov/pubmed/27512204 http://dx.doi.org/10.4103/0019-5154.185745 |